Data derived from PhenomiR
PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
16966691 |
Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) |
Cancer |
pancreas |
miRNA overexpression |
- |
2.94 |
- |
Patient study phenotype-control |
miRNA microarray
|
16966691 |
Pancreatic cancer - 260350 (Pancreatic acinar cell carcinoma - 0) |
Cancer |
pancreatic acinar cell |
miRNA overexpression |
- |
3.46 |
- |
Patient study phenotype-control |
miRNA microarray
|
18230780 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA overexpression |
- |
1.2 |
- |
Patient study phenotype-control |
quantitative PCR
|
18607389 |
Colorectal cancer - 114500 |
Cancer |
colorectum |
miRNA overexpression |
- |
1.1 |
- |
Patient study phenotype-control |
quantitative PCR
|
18560586 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary |
miRNA downregulation |
- |
2.5641 |
- |
Patient study phenotype-control |
miRNA microarray
|
17283129 |
Neuroblastoma - 256700 |
Cancer |
neuroblastoma cell |
miRNA downregulation |
- |
2.22 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
17934639 |
Leukemia, chronic lymphatic, susceptibility to - 151400 |
Cancer |
bone marrow |
miRNA overexpression |
- |
1.82 |
- |
Patient study phenotype-control |
quantitative PCR
|
17934639 |
Cancer - 0 (Leukemia, acute lymphoblastic - 0) |
Cancer |
bone marrow |
miRNA overexpression |
- |
2.32 |
- |
Patient study phenotype-control |
quantitative PCR
|
17942673 |
Duchenne muscular dystrophy - 310200 |
Muscular |
muscle |
miRNA overexpression |
- |
3.79 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
3.0 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2A - 253600 |
Muscular |
muscle |
miRNA overexpression |
- |
4.1 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2B - 253601 |
Muscular |
muscle |
miRNA overexpression |
- |
6.68 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Miyoshi myopathy - 254130 |
Muscular |
muscle |
miRNA overexpression |
- |
2.64 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Myopathy, nemaline, 3 - 161800 |
Muscular |
muscle |
miRNA overexpression |
- |
8.34 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular - 0 (Dermatomyositis - 0) |
Muscular |
muscle |
miRNA overexpression |
- |
3.35 |
- |
Patient study phenotype-control |
miRNA microarray
|
17622355 |
Dermatitis, atopic - 603165 |
Dermatological |
skin |
miRNA downregulation |
- |
1.78 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.05307 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA overexpression |
- |
1.3294 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.07458 |
- |
Patient study phenotype-control |
miRNA microarray
|
16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA downregulation |
- |
16.6667 |
- |
Cell culture study |
quantitative PCR
|
18700954 |
Multiple myeloma - 254500 |
Cancer |
plasma cell |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA overexpression |
- |
2.47 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA overexpression |
- |
2.1 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA downregulation |
- |
3.22581 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA overexpression |
- |
2.53 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18728182 |
Multiple myeloma - 254500 |
Cancer |
plasma cell |
miRNA downregulation |
- |
9.09091 |
- |
Patient study phenotype-control |
miRNA microarray
|
16754881 |
Ovarian cancer - 604370 |
Cancer |
ovary |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA overexpression |
- |
- |
- |
Cell culture study |
array CGH
|
16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA downregulation |
- |
25.0 |
- |
Cell culture study |
quantitative PCR
|
17922033 |
Rhabdomyosarcoma - 268210 |
Cancer |
myoblast |
miRNA overexpression |
- |
6.68 |
- |
Patient study phenotype-control |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA downregulation |
- |
20.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA downregulation |
- |
10.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
DU-145 cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
Tsu-Pr1 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
LNCaP cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
20.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
18766170 |
Lung cancer - 211980 |
Cancer |
serum |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
deep sequencing
|
16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA downregulation |
- |
33.3333 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA downregulation |
- |
12.5 |
- |
Cell culture study |
quantitative PCR
|
18607389 |
- |
- |
embryo |
miRNA overexpression |
- |
2.49 |
- |
Bioprocess study |
quantitative PCR
|
17765232 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA overexpression |
- |
2.48 |
- |
Patient study phenotype-control |
miRNA microarray
|
17379065 |
- |
- |
cord blood stem cell |
miRNA overexpression |
- |
- |
- |
Bioprocess study |
miRNA microarray
|
16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
17191223 |
- |
- |
lung |
miRNA downregulation |
- |
- |
- |
Bioprocess study |
quantitative PCR
|